Family Medicine · Van Nuys, CA
NPI
1558543280
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
14600 Sherman Way Ste 280
Van Nuys, CA, 91405
Phone (818) 781-3110
Groups this clinician bills Medicare through
Medicare paid, 2024
$721K
36,874 services
Medicare patients, 2024
1,204
Average age 74
Drug cost, 2024
$4.8M
76,258 prescriptions
Company payments, 2025
$577
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Garbis Apelian was code 99213 (office e&m - established), 3,260 times for 1,138 patients. In total Garbis Apelian billed 36,874 services in 46 codes, and Medicare paid $721K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 3,260 | 1,138 | $68.38 | $223K |
| 80076 Clinical Chemistry | Office | 2,221 | 1,058 | $8.02 | $18K |
| 83735 Clinical Chemistry | Office | 2,220 | 1,058 | $6.57 | $15K |
| 84550 Clinical Chemistry | Office | 2,220 | 1,058 | $4.44 | $9,848 |
| 83036 Blood Count | Office | 2,220 | 1,058 | $9.53 | $21K |
| 84439 Clinical Chemistry | Office | 2,220 | 1,058 | $8.84 | $20K |
| 84443 Clinical Chemistry | Office | 2,219 | 1,058 | $16.46 | $37K |
| 82728 Clinical Chemistry | Office | 2,217 | 1,058 | $13.36 | $30K |
| 85025 Blood Count | Office | 2,216 | 1,057 | $7.61 | $17K |
| 80048 Clinical Chemistry | Office | 2,214 | 1,056 | $8.29 | $18K |
| 82746 Clinical Chemistry | Office | 2,211 | 1,058 | $14.40 | $32K |
| 80061 Clinical Chemistry | Office | 2,209 | 1,058 | $13.12 | $29K |
| 36415 Venipuncture Blood Collection | Office | 2,207 | 1,054 | $8.65 | $19K |
| 82607 Clinical Chemistry | Office | 2,052 | 1,040 | $14.78 | $30K |
| 83540 Clinical Chemistry | Office | 1,772 | 991 | $6.34 | $11K |
By year: 2022 $864K for 40,454 services; 2023 $764K for 38,659 services; 2024 $721K for 36,874 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80076 Clinical Chemistry | 2,221 | 1,058 | $8.02 | $18K |
| 84550 Clinical Chemistry | 2,220 | 1,058 | $4.44 | $9,848 |
| 83036 Blood Count | 2,220 | 1,058 | $9.53 | $21K |
| 84439 Clinical Chemistry | 2,220 | 1,058 | $8.84 | $20K |
| 83735 Clinical Chemistry | 2,220 | 1,058 | $6.57 | $15K |
| 84443 Clinical Chemistry | 2,219 | 1,058 | $16.46 | $37K |
| 82728 Clinical Chemistry | 2,217 | 1,058 | $13.36 | $30K |
| 85025 Blood Count | 2,216 | 1,057 | $7.61 | $17K |
| 80048 Clinical Chemistry | 2,214 | 1,056 | $8.29 | $18K |
| 82746 Clinical Chemistry | 2,211 | 1,058 | $14.40 | $32K |
Medicare prescription drug claims, 2024
In 2024, the drug Garbis Apelian prescribed most often to Medicare patients was Amlodipine Besylate, with 3,650 prescriptions and refills. In total Garbis Apelian wrote 76,258 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 3,650 | 4,306 | 441 | $4,562 |
| Atorvastatin Calcium Generic | 2,662 | 3,207 | 326 | $8,225 |
| Rosuvastatin Calcium Generic | 2,362 | 2,760 | 302 | $9,893 |
| Meclizine Hcl Generic | 2,179 | 2,244 | 266 | $8,753 |
| Omeprazole Generic | 2,102 | 2,405 | 264 | $5,671 |
| Gabapentin Generic | 2,069 | 2,191 | 252 | $5,600 |
| Losartan Potassium Generic | 1,924 | 2,301 | 246 | $4,669 |
| Ibuprofen Generic | 1,862 | 1,912 | 259 | $6,116 |
| Metformin Hcl Generic | 1,686 | 1,983 | 221 | $26K |
| Clonidine Hcl Generic | 1,516 | 1,583 | 166 | $1,793 |
| Levothyroxine Sodium Generic | 1,305 | 1,512 | 145 | $5,022 |
| Metoprolol Succinate Generic | 1,295 | 1,456 | 155 | $6,319 |
| Dexlansoprazole Dr Dexlansoprazole | 1,243 | 1,300 | 158 | $205K |
| Escitalopram Oxalate Generic | 1,233 | 1,354 | 148 | $3,139 |
| Furosemide Generic | 1,190 | 1,303 | 141 | $1,541 |
Brand drugs: 10,004 claims; generic drugs: 64,953 claims; opioid claims: 581.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Garbis Apelian $577 ($577 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $197 |
| Ardelyx, Inc. ARDX | 4 | $117 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $76.28 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $46.83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $41.03 |
| Radius Health, Inc. | 1 | $32.8 |
| Lilly USA, LLC LLY | 1 | $25.93 |
| Viatris Specialty LLC | 1 | $25.48 |
| Shield Therapeutics Inc STX.L | 1 | $14.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.